We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Dr. Schwartz is a highly-experienced biotechnology executive currently serving as COO of Theracaine, Director of Targazyme Inc., and adviser to several early stage companies. He is adjunct faculty at San Jose State Un. with appointments in the Masters in Biotechnology Program, the Lucas School of Management in the Business College, and the department of Biology. Dr. Schwartz has extensive experience in growing startup ventures as well as managing public biotechnology companies. Dr. Schwartz has held senior management, research and board positions in multiple life science industries including therapeutics, diagnostics, and research products. Dr. Schwartz serves on the advisory board of CEI in Phoenix, and the Biotech Advisory Board of Arizona State Un. Dr. Schwartz’s leadership has resulted in significant corporate developments including the growth and maturation of early stage startups as well as liquidity events and returns to shareholders in numerous companies.
This speaker's sessions: